United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CFO James Edgemond sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $549.17, for a total transaction of $5,491,700.00. Following the transaction, the chief financial officer owned 18,876 shares of the […]

Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) Director Timothy Coughlin sold 10,000 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $50.07, for a total transaction of $500,700.00. Following the sale, the director owned 56,250 shares in the company, valued at $2,816,437.50. […]

Oruka Therapeutics, Inc. (NASDAQ:ORKA – Get Free Report) CEO Lawrence Otto Klein sold 1,729 shares of the firm’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $69.69, for a total transaction of $120,494.01. Following the transaction, the chief executive officer directly owned 925,580 shares in the […]

Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) insider William Guyer sold 20,000 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $70.60, for a total transaction of $1,412,000.00. Following the completion of the transaction, the insider directly owned 3,985 shares of […]

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider David Kirn sold 1,922 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.02, for a total transaction of $19,258.44. Following the transaction, the insider owned 1,057,231 shares of the company’s stock, valued […]